Pirouette Pharma
PrivateLast Round
Seed Round
Mar 18, 2026
Est. Valuation
$55M
Total Funding Raised
$15.63M
Company Overview
Pirouette Pharma is a pharmaceutical company developing a platform of automated, disk-shaped auto-injectors designed for affordability, portability, and ease of use. The company's mission is to make administering injections as simple as pushing a button, initially focusing on emergency medications like epinephrine for severe allergic reactions and naloxone for opioid overdoses. Founded in 2017 by alumni from Clarkson University, MIT, and Harvard, the company is backed by investors including Y Combinator, Safar Partners, and Liquid 2 Ventures. Pirouette Pharma operates a 10,000 sqft manufacturing facility in Portsmouth, NH, and aims to expand its platform for use with other injectable drugs for conditions requiring routine care, such as IVF and vaccines. The company rebranded from Pirouette Medical to Pirouette Pharma to reflect its focus on combination products (drug and device) which are regulated as pharmaceutical therapies.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Patient Engagement
Business Model
B2G
Customer Profile
Hardware Sales, Government Contracts, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pirouette Pharma Comps
Public and private peers based on sector, stage, and business model.
Pirouette Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Mar 18, 2026 | ||||
| Crowdfunding | Mar 14, 2025 | ||||
| Series A Extension | May 31, 2022 | ||||
| Series A | Aug 19, 2021 | ||||
| Seed | Jun 22, 2021 | ||||
Accelerator | Jun 1, 2021 |
Key People
Founding team and executive leadership
Pirouette Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Gaingels | Crowdfunding, Series A |
| Magic Fund | Crowdfunding |
| Safar Partners | Crowdfunding, Series A, Seed |
| Asymmetry Ventures | Crowdfunding |
| Y Combinator | Crowdfunding, Series A, Accelerator |
| Liquid 2 Ventures | Crowdfunding, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 18, 2026
$1.08M raised in Seed Round.
Pirouette Pharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Pirouette Pharma's valuation, stock price, and market status.
